DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Global Health Limited — Change in Management

NSE 1 hr ago·2 Nov 2026, 11:56 am

Global Health

Global Health Limited, the operator of Medanta Medicity, has announced a change in its senior management. The company has informed the stock exchanges about this shift in leadership, though specific details regarding the change have not been disclosed at this time.

For investors, this development is noteworthy as leadership changes can impact the strategic direction and operational focus of a healthcare company. It is important to monitor how this transition might affect the hospital's future growth plans and operational efficiency.

Investors should watch for official announcements from the company regarding the new leadership's vision and strategy. Keeping an eye on operational updates and future guidance will be crucial to understanding the long-term impact of this management change on Medanta's stock performance.